Clinical trial
Innovating CBT-I for Cancer Survivors: An Optimization Trial
NCT06181643 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Innovating CBT-I for Cancer Survivors: An Optimization Trial
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 6, 2024
- Completion date
- May 31, 2026
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer survivorship, insomnia